Features
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Technology Evolution
Handling of high potency compounds for API and DP from development on a laboratory scale and scale-up to commercial.Martina Kotthaus, Jeff Dinyer, Anil Kane and Marvin Faber, Patheon, part of Thermo Fisher Scientific 09.11.18
-
Clinical Trial Materials | Supply Chain
Supply Chain Olympics
Clinical trial supply chain management: Changing without delayAdam Runsdorf, President WDPrx - Woodfield Pharmaceutical, LLC 09.11.18
-
Biosimilars
Biosimilar Market Trends
2017 was a record year for biosimilar approvals.Fiona Greer and Bruno Speder, SGS 09.11.18
-
Biologics, Proteins, Vaccines | Injectables
Next-Gen Biologics Packaging & Delivery
As the frontier of drug innovation evolves, so must the design of packaging and delivery systems.09.11.18
-
cGMP Manufacture | Solid Dosage/Creams/Ointments
Continuous Pharmaceutical Manufacturing
Exploring the advantages of continuous over batch manufactureShawn Conway, Ph.D. and Daniel Bowles, Ph.D., Cambrex 09.11.18
-
Solid Dosage/Creams/Ointments
Solid Dosage Manufacturing
Solving common problems in solid dose manufacturingMike Tousey, CEO and Technical Director, Techceuticals LLC 09.11.18
-
Biologics, Proteins, Vaccines | Biosimilars | Drug Development
Haste Makes Waste
When to sprint and when to breathe in the race from lab to clinic.Christian Cattaruzza, MilliporeSigma 09.11.18
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth.Nigel Walker, That’s Nice/Nice Insight 09.11.18
-
Global Outsourcing Strategies
As the market for outsourcing continues to grow, so too have the types of outsourcing models sponsors have to choose from.Colin Stanley, President, ICON Functional Services 09.11.18
-
Clinical Trial Materials | Supply Chain
Clinical Trial Supplies Planning and Management
There are a significant number of factors that affect the complexity of planning and managing clinical supplies.Kristen DeVito, Global Director, Clinical Supply Business Solutions, Catalent 09.11.18
-
cGMP Manufacture | Drug Development
Benefits of the One-Stop-Shop CDMO
One provider for many solutions can offer support for the entire product value chainDr. David Brett, Vetter Pharma International GmbH 09.11.18
-
Top 25 Pharma and Biopharma Companies
Combined sales for 2017 reached $599 billion. (Based on 2017 Pharma/Biopharma Sales, in $U.S. Millions)07.23.18
-
19th Annual Salary & Job Satisfaction Survey
Welcome to Contract Pharma's 19th Annual Salary & Job Satisfaction Survey!Tim Wright, Editor 06.13.18
-
Biologics, Proteins, Vaccines
Newsmakers: Flash Therapeutics
Recent merger creates new cell therapy CDMOKristin Brooks, Managing Editor 06.13.18
-
-
Pre-clinical CRO Evaluation
A framework to evaluate pre-clinical CRO vendors based on both technical and commercial capabilitiesAnne Gimalac, Senior Business Consultant, Aston Life Sciences 06.12.18
-
Drug Development
Journeying with CROs: Driving drug development efficiency
Multi-service CROs can deliver quality, efficiency, and cost reductions for drug developers.Lynn Lewis, Chief Commercial Officer, Envigo 06.12.18
-
Inspections | Regulatory Affairs
PAI Readiness – A Journey, not an Event
A look at what you need to do to get ready for a pre-approval inspectionDr. Walter Matzmorr, Tunnell Consulting 06.12.18
-
Formulation Development
Developing Faster-to-Clinic Formulations
When standard formulation strategies fail, is there a fast path to clinic for hard-to-formulate therapeutics?Phil Morton, Chief Technology Officer, Albumedix 06.12.18
-
Drug Delivery | Drug Development
Traveling Toward the Intersection of Drug Development and Delivery
Overcoming the challenges of delivering drugs to patients.Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems 06.12.18
